MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
December 29, 2023 17:00 ET
|
MiMedx Group, Inc
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently Under Review Reiterates Expectations for...
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
December 28, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that its outstanding 95,000 shares of Series B Convertible Preferred...
MIMEDX to Participate in Upcoming Investor Conferences
November 13, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 13, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following...
MIMEDX to Highlight Published Data at SAWC Fall
November 02, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it will sponsor an Innovation Theater lunch symposium at the Symposium...
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
October 30, 2023 16:01 ET
|
MiMedx Group, Inc
Third Consecutive Quarter of Net Sales Growth Exceeding 20% Over the Prior Year Period Raises Full-Year 2023 Net Sales Percentage Growth Outlook to the High Teens MARIETTA, Ga., Oct. 30, 2023 ...
MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference Call on October 30
October 16, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third...
MIMEDX Announces Launch of EPIEFFECT™
September 26, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the launch of EPIEFFECT™, the Company’s latest addition to its...
MIMEDX to Present at Upcoming Investor Conferences
September 05, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the following investor...
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
August 01, 2023 16:01 ET
|
MiMedx Group, Inc
Records Second Quarter Net Sales of $81.3 Million; an Increase of 21.5% Over the Prior Year Period Increases Full-Year 2023 Guidance for Net Sales Growth Welcomes Highly Successful MedTech Executive...
MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1
July 18, 2023 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., July 18, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second...